Center for Drug Design - University of Minnesota

Research ServicesUnited States51-200 Employees

The Center for Drug Design was conceived by Robert Vince, PhD, medicinal chemist and drug discovery researcher at the University of Minnesota. He is the holder of dozens of patents in the anti-cancer, anti-viral, and anti-microbial fields. One of his most significant contributions was the design of carbovir, a potent anti-HIV/AIDS drug; commercially available and sold as Ziagen® by GlaxoSmithKline Pharmaceutical Company. With the guiding principle of uniting high-level research with the design and development of highly effective drugs, Dr. Vince obtained the approval of Senior Vice President, Frank Cerra, MD, and the Council of Deans (Academic Health Center, University of Minnesota) for the Center’s creation. On January 8, 2002, the Center for Drug Design was established as a center of excellence in drug design and research. 

As part of the College of Pharmacy at the University of Minnesota, the CDD combines the best of academic tradition with an expectation of innovation and independence, to inspire and drive our Center members to excel, and to provide value for the academic and research community.

Sign up for free to view info

Email Format Employee directory